Shalby Limited SHALBY.NS · Stock Open Shalby Limited in new tab
Shalby Limited Analysis (SHALBY.NS)
Is Shalby Limited a good investment? Shalby Limited (SHALBY.NS) is currently trading at 171.62 INR.
In terms of valuation, the stock trades at a P/E ratio of 52.72. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Shalby Limited is expected to release its next earnings report on Sept. 7, 2026. The market consensus estimate for Forward EPS is 9.40.
Investor FAQ
Does Shalby Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Shalby Limited?
Shalby Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Sept. 7, 2026. The company currently has a trailing EPS of 3.24.
Company Profile
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neurology, ideal stroke treatment, epilepsy, endovascular/interventional neurosurgery, and trans cranial doppler; obstetrics and gynaecology; surgical oncology, medical oncology, radiation oncology, bone marrow transplant, onco-psychology, onco-dietetics, onco-physiotherapy, and home care; ophthalmology; paediatrics; pathology and microbiology; psychiatry; pulmonology and chest; and interventional and diagnostic radiology. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is based in Ahmedabad, India.
| Year | Total Dividends |
|---|---|
| ▸2024 |
1.20 INR
|
| Oct. 1, 2024 | 1.2000 |
| ▸2023 |
1.20 INR
|
| Sept. 13, 2023 | 1.2000 |
| ▸2022 |
1.00 INR
|
| Oct. 26, 2022 | 1.0000 |
| ▸2021 |
1.00 INR
|
| Oct. 27, 2021 | 1.0000 |
| ▸2020 |
0.50 INR
|
| Oct. 14, 2020 | 0.5000 |
| ▸2019 |
0.50 INR
|
| Sept. 25, 2019 | 0.5000 |
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 22, 2022 | 1.200000 |
Community Discussion